[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Ocular Drug Delivery Market Report 2017

July 2017 | 100 pages | ID: A1108264EDAEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Ocular Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Doses), revenue (Million USD), market share and growth rate of Ocular Drug Delivery for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Ocular Drug Delivery market competition by top manufacturers/players, with Ocular Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • OCULAR THERAPEUTIX, INC
  • Alimera Sciences
  • Allergan, Plc
  • EyeGate Pharma
  • Valeant Pharmaceuticals International, Inc
  • Envisia Therapeutics
  • Clearside Biomedical
  • Graybug Vision Inc
  • Taiwan Liposome Company
  • Santen Pharmaceutical Co., Ltd
On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into
  • Ocular Insert
  • Iontophoresis
  • Intraocular Implants
  • In Situ Gel & Punctal Plugs
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Doses), market share and growth rate of Ocular Drug Delivery for each application, includin
  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmic Clinics
  • Homecare Settings
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Ocular Drug Delivery Market Report 2017

1 OCULAR DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Ocular Drug Delivery
1.2 Classification of Ocular Drug Delivery by Product Category
  1.2.1 Asia-Pacific Ocular Drug Delivery Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Ocular Drug Delivery Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Ocular Insert
  1.2.4 Iontophoresis
  1.2.5 Intraocular Implants
  1.2.6 In Situ Gel & Punctal Plugs
  1.2.7 Others
1.3 Asia-Pacific Ocular Drug Delivery Market by Application/End Users
  1.3.1 Asia-Pacific Ocular Drug Delivery Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospitals
  1.3.3 Ambulatory Surgical Centers
  1.3.4 Ophthalmic Clinics
  1.3.5 Homecare Settings
1.4 Asia-Pacific Ocular Drug Delivery Market by Region
  1.4.1 Asia-Pacific Ocular Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Ocular Drug Delivery (2012-2022)
  1.5.1 Asia-Pacific Ocular Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Ocular Drug Delivery Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC OCULAR DRUG DELIVERY COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Ocular Drug Delivery Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Ocular Drug Delivery Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Ocular Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Ocular Drug Delivery (Volume and Value) by Type
  2.2.1 Asia-Pacific Ocular Drug Delivery Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Ocular Drug Delivery Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Ocular Drug Delivery (Volume) by Application
2.4 Asia-Pacific Ocular Drug Delivery (Volume and Value) by Region
  2.4.1 Asia-Pacific Ocular Drug Delivery Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Ocular Drug Delivery Revenue and Market Share by Region (2012-2017)

3 CHINA OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

3.1 China Ocular Drug Delivery Sales and Value (2012-2017)
  3.1.1 China Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  3.1.3 China Ocular Drug Delivery Sales Price Trend (2012-2017)
3.2 China Ocular Drug Delivery Sales Volume and Market Share by Type
3.3 China Ocular Drug Delivery Sales Volume and Market Share by Application

4 JAPAN OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Ocular Drug Delivery Sales and Value (2012-2017)
  4.1.1 Japan Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Ocular Drug Delivery Sales Price Trend (2012-2017)
4.2 Japan Ocular Drug Delivery Sales Volume and Market Share by Type
4.3 Japan Ocular Drug Delivery Sales Volume and Market Share by Application

5 SOUTH KOREA OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Ocular Drug Delivery Sales and Value (2012-2017)
  5.1.1 South Korea Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Ocular Drug Delivery Sales Price Trend (2012-2017)
5.2 South Korea Ocular Drug Delivery Sales Volume and Market Share by Type
5.3 South Korea Ocular Drug Delivery Sales Volume and Market Share by Application

6 TAIWAN OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Ocular Drug Delivery Sales and Value (2012-2017)
  6.1.1 Taiwan Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Ocular Drug Delivery Sales Price Trend (2012-2017)
6.2 Taiwan Ocular Drug Delivery Sales Volume and Market Share by Type
6.3 Taiwan Ocular Drug Delivery Sales Volume and Market Share by Application

7 INDIA OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

7.1 India Ocular Drug Delivery Sales and Value (2012-2017)
  7.1.1 India Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  7.1.3 India Ocular Drug Delivery Sales Price Trend (2012-2017)
7.2 India Ocular Drug Delivery Sales Volume and Market Share by Type
7.3 India Ocular Drug Delivery Sales Volume and Market Share by Application

8 SOUTHEAST ASIA OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Ocular Drug Delivery Sales and Value (2012-2017)
  8.1.1 Southeast Asia Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Ocular Drug Delivery Sales Price Trend (2012-2017)
8.2 Southeast Asia Ocular Drug Delivery Sales Volume and Market Share by Type
8.3 Southeast Asia Ocular Drug Delivery Sales Volume and Market Share by Application

9 AUSTRALIA OCULAR DRUG DELIVERY (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Ocular Drug Delivery Sales and Value (2012-2017)
  9.1.1 Australia Ocular Drug Delivery Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Ocular Drug Delivery Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Ocular Drug Delivery Sales Price Trend (2012-2017)
9.2 Australia Ocular Drug Delivery Sales Volume and Market Share by Type
9.3 Australia Ocular Drug Delivery Sales Volume and Market Share by Application

10 ASIA-PACIFIC OCULAR DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 OCULAR THERAPEUTIX, INC
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Ocular Drug Delivery Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Alimera Sciences
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Ocular Drug Delivery Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Alimera Sciences Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Allergan, Plc
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Ocular Drug Delivery Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Allergan, Plc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 EyeGate Pharma
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Ocular Drug Delivery Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 EyeGate Pharma Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Valeant Pharmaceuticals International, Inc
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Ocular Drug Delivery Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Envisia Therapeutics
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Ocular Drug Delivery Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Envisia Therapeutics Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Clearside Biomedical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Ocular Drug Delivery Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Clearside Biomedical Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Graybug Vision Inc
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Ocular Drug Delivery Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Graybug Vision Inc Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Taiwan Liposome Company
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Ocular Drug Delivery Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Santen Pharmaceutical Co., Ltd
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Ocular Drug Delivery Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 OCULAR DRUG DELIVERY MANUFACTURING COST ANALYSIS

11.1 Ocular Drug Delivery Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Ocular Drug Delivery

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Ocular Drug Delivery Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC OCULAR DRUG DELIVERY MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Ocular Drug Delivery Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Ocular Drug Delivery Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Ocular Drug Delivery Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Ocular Drug Delivery Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Ocular Drug Delivery Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Ocular Drug Delivery Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Ocular Drug Delivery Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Ocular Drug Delivery Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Ocular Drug Delivery Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Ocular Drug Delivery Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Ocular Drug Delivery Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Ocular Drug Delivery Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Ocular Drug Delivery Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Ocular Drug Delivery
Figure Asia-Pacific Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2022)
Figure Asia-Pacific Ocular Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Ocular Insert Product Picture
Figure Iontophoresis Product Picture
Figure Intraocular Implants Product Picture
Figure In Situ Gel & Punctal Plugs Product Picture
Figure Others Product Picture
Figure Asia-Pacific Ocular Drug Delivery Sales (K Doses) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Ocular Drug Delivery by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Ophthalmic Clinics Examples
Table Key Downstream Customer in Ophthalmic Clinics
Figure Homecare Settings Examples
Table Key Downstream Customer in Homecare Settings
Figure Asia-Pacific Ocular Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure China Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Ocular Drug Delivery Sales Volume (K Doses) and Growth Rate (2012-2022)
Figure Asia-Pacific Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Ocular Drug Delivery Market Major Players Product Sales Volume (K Doses)(2012-2017)
Table Asia-Pacific Ocular Drug Delivery Sales (K Doses) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Ocular Drug Delivery Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Ocular Drug Delivery Sales Share by Players/Suppliers
Figure Asia-Pacific Ocular Drug Delivery Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Ocular Drug Delivery Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Ocular Drug Delivery Revenue Share by Players
Figure 2017 Asia-Pacific Ocular Drug Delivery Revenue Share by Players
Table Asia-Pacific Ocular Drug Delivery Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Sales Share by Type (2012-2017)
Figure Sales Market Share of Ocular Drug Delivery by Type (2012-2017)
Figure Asia-Pacific Ocular Drug Delivery Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery by Type (2012-2017)
Figure Asia-Pacific Ocular Drug Delivery Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Sales Volume (K Doses) and Market Share by Region (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Sales Share by Region (2012-2017)
Figure Sales Market Share of Ocular Drug Delivery by Region (2012-2017)
Figure Asia-Pacific Ocular Drug Delivery Sales Market Share by Region in 2016
Table Asia-Pacific Ocular Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Ocular Drug Delivery by Region (2012-2017)
Figure Asia-Pacific Ocular Drug Delivery Revenue Market Share by Region in 2016
Table Asia-Pacific Ocular Drug Delivery Sales Volume (K Doses) and Market Share by Application (2012-2017)
Table Asia-Pacific Ocular Drug Delivery Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Ocular Drug Delivery Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Ocular Drug Delivery Sales Market Share by Application (2012-2017)
Figure China Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure China Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table China Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table China Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure China Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table China Ocular Drug Delivery Sales Volume (K Doses) by Applications (2012-2017)
Table China Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure China Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Figure Japan Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Japan Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table Japan Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table Japan Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Japan Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table Japan Ocular Drug Delivery Sales Volume (K Doses) by Applications (2012-2017)
Table Japan Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Japan Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Figure South Korea Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure South Korea Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table South Korea Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table South Korea Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure South Korea Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table South Korea Ocular Drug Delivery Sales Volume (K Doses) by Applications (2012-2017)
Table South Korea Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure South Korea Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Figure Taiwan Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Taiwan Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table Taiwan Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table Taiwan Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table Taiwan Ocular Drug Delivery Sales Volume (K Doses) by Applications (2012-2017)
Table Taiwan Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Figure India Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure India Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table India Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table India Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure India Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table India Ocular Drug Delivery Sales Volume (K Doses) by Application (2012-2017)
Table India Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure India Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Figure Southeast Asia Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Southeast Asia Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table Southeast Asia Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table Southeast Asia Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table Southeast Asia Ocular Drug Delivery Sales Volume (K Doses) by Applications (2012-2017)
Table Southeast Asia Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Figure Australia Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Australia Ocular Drug Delivery Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Ocular Drug Delivery Sales Price (USD/Dose) Trend (2012-2017)
Table Australia Ocular Drug Delivery Sales Volume (K Doses) by Type (2012-2017)
Table Australia Ocular Drug Delivery Sales Volume Market Share by Type (2012-2017)
Figure Australia Ocular Drug Delivery Sales Volume Market Share by Type in 2016
Table Australia Ocular Drug Delivery Sales Volume (K Doses) by Applications (2012-2017)
Table Australia Ocular Drug Delivery Sales Volume Market Share by Application (2012-2017)
Figure Australia Ocular Drug Delivery Sales Volume Market Share by Application in 2016
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Basic Information List
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Alimera Sciences Ocular Drug Delivery Basic Information List
Table Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Alimera Sciences Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Allergan, Plc Ocular Drug Delivery Basic Information List
Table Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Allergan, Plc Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table EyeGate Pharma Ocular Drug Delivery Basic Information List
Table EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure EyeGate Pharma Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Basic Information List
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Envisia Therapeutics Ocular Drug Delivery Basic Information List
Table Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Envisia Therapeutics Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Clearside Biomedical Ocular Drug Delivery Basic Information List
Table Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Clearside Biomedical Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Graybug Vision Inc Ocular Drug Delivery Basic Information List
Table Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Graybug Vision Inc Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Taiwan Liposome Company Ocular Drug Delivery Basic Information List
Table Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Taiwan Liposome Company Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Basic Information List
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses) and Growth Rate (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales Market Share in Asia-Pacific (2012-2017)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Dose) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery
Figure Manufacturing Process Analysis of Ocular Drug Delivery
Figure Ocular Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Ocular Drug Delivery Major Manufacturers in 2016
Table Major Buyers of Ocular Drug Delivery
Table Distributors/Traders List
Figure Asia-Pacific Ocular Drug Delivery Sales Volume (K Doses) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Price (USD/Dose) and Trend Forecast (2017-2022)
Table Asia-Pacific Ocular Drug Delivery Sales Volume (K Doses) Forecast by Region (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Ocular Drug Delivery Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Revenue Market Share Forecast by Region in 2022
Figure China Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure China Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Japan Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure South Korea Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Taiwan Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure India Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Ocular Drug Delivery Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure Australia Ocular Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Ocular Drug Delivery Sales (K Doses) Forecast by Type (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Ocular Drug Delivery Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Ocular Drug Delivery Price (USD/Dose) Forecast by Type (2017-2022)
Table Asia-Pacific Ocular Drug Delivery Sales (K Doses) Forecast by Application (2017-2022)
Figure Asia-Pacific Ocular Drug Delivery Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories